Business Description
Bionime Corp
ISIN : TW0004737002
Total Employee Number:
671Description
Bionime Corp is engaged in the manufacturing and selling of medical instruments, providing biotechnology services, examining pharmaceuticals, and selling precision instruments. The company's revenue is derived from the sale of blood glucose meters and test strips to domestic and foreign clients. Geographically, it operates in Algeria, China, Switzerland, the United States, Belarus, Egypt, the United Arab Emirates, and other countries, of which it derives the maximum revenue from Algeria.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.16 | |||||
Equity-to-Asset | 0.31 | |||||
Debt-to-Equity | 1.75 | |||||
Debt-to-EBITDA | -1375.16 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 0.73 | |||||
Beneish M-Score | -3.09 | |||||
WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -5.8 | |||||
3-Year Book Growth Rate | -5.8 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 51.49 | |||||
9-Day RSI | 51.31 | |||||
14-Day RSI | 49.45 | |||||
3-1 Month Momentum % | -21.76 | |||||
6-1 Month Momentum % | 0.43 | |||||
12-1 Month Momentum % | -18.99 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.75 | |||||
Quick Ratio | 0.53 | |||||
Cash Ratio | 0.23 | |||||
Days Inventory | 158.27 | |||||
Days Sales Outstanding | 110.92 | |||||
Days Payable | 48.05 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.3 | |||||
Shareholder Yield % | -2.62 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 34.15 | |||||
Operating Margin % | -11.05 | |||||
Net Margin % | -9.81 | |||||
EBITDA Margin % | -0.12 | |||||
FCF Margin % | 11.23 | |||||
OCF Margin % | 26.91 | |||||
ROE % | -9.76 | |||||
ROA % | -3.17 | |||||
ROIC % | -2.67 | |||||
3-Year ROIIC % | -21.67 | |||||
ROC (Joel Greenblatt) % | -5.68 | |||||
ROCE % | -5.06 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 55.04 | |||||
Shiller PE Ratio | 53.43 | |||||
Price-to-Owner-Earnings | 18.93 | |||||
PS Ratio | 2.1 | |||||
PB Ratio | 2.21 | |||||
Price-to-Tangible-Book | 4.66 | |||||
Price-to-Free-Cash-Flow | 18.68 | |||||
Price-to-Operating-Cash-Flow | 7.79 | |||||
EV-to-EBIT | -37.76 | |||||
EV-to-EBITDA | -3131.24 | |||||
EV-to-Revenue | 3.79 | |||||
EV-to-FCF | 33.75 | |||||
Price-to-GF-Value | 0.96 | |||||
Price-to-Projected-FCF | 7.09 | |||||
Price-to-Median-PS-Value | 0.97 | |||||
Earnings Yield (Greenblatt) % | -2.65 | |||||
FCF Yield % | 4.71 | |||||
Forward Rate of Return (Yacktman) % | -28 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bionime Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 1,838.588 | ||
| EPS (TTM) (NT$) | -2.653 | ||
| Beta | 0.3315 | ||
| 3-Year Sharpe Ratio | -0.26 | ||
| 3-Year Sortino Ratio | -0.5 | ||
| Volatility % | 32.83 | ||
| 14-Day RSI | 49.45 | ||
| 14-Day ATR (NT$) | 2.033681 | ||
| 20-Day SMA (NT$) | 56.125 | ||
| 12-1 Month Momentum % | -18.99 | ||
| 52-Week Range (NT$) | 49.75 - 73.186109 | ||
| Shares Outstanding (Mil) | 77.29 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bionime Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bionime Corp Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| 1.09986:1 Stock Split | 2025-09-08 | 70.50 (+3.03%) | ||
| TWD 1.800829 Cash Dividend | 2024-07-29 | 61.14 (+0.44%) | ||
| 1.1:1 Stock Split | 2011-07-22 | 97.00 (-0.41%) |
Show
Entries
Bionime Corp Frequently Asked Questions
What is Bionime Corp(TPE:4737)'s stock price today?
The current price of TPE:4737 is NT$56.70. The 52 week high of TPE:4737 is NT$73.19 and 52 week low is NT$49.75.
When is next earnings date of Bionime Corp(TPE:4737)?
The next earnings date of Bionime Corp(TPE:4737) is .
Does Bionime Corp(TPE:4737) pay dividends? If so, how much?
Bionime Corp(TPE:4737) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Bionime Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers